Correction: Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from second-line immunotherapy in NSCLC

Detalles Bibliográficos
Autores principales: Ismail, R. K., Schramel, F. M. N. H., van Dartel, M., Pasmooij, A. M. G., der Welle, C. M. Cramer-van, Hilarius, D. L., de Boer, A., Wouters, M. W. J. M., van de Garde, E. M. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881308/
https://www.ncbi.nlm.nih.gov/pubmed/36707787
http://dx.doi.org/10.1186/s12874-023-01850-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881308/
https://www.ncbi.nlm.nih.gov/pubmed/36707787
http://dx.doi.org/10.1186/s12874-023-01850-7

Ejemplares similares